SME Times is powered by   
Search News
Just in:   • India-Chile FTA ripe for conclusion, Canada talks progressing well: Piyush Goyal  • Sensex, Nifty end higher in volatile trade; metal and pharma stocks lead gains  • Centre notifies 'E100' fuel norms for flex-fuel vehicles  • Govt extends RELIEF scheme for risk coverage of export shipments due to Gulf war  • Tesla India posts Rs 247 crore revenue in first fiscal of vehicle sales 
Last updated: 26 Dec, 2021  

BSE.9.Thmb.jpg Resurgent Covid, macro-data to drive equities

BSE.9.jpg
   Top Stories
» India-Chile FTA ripe for conclusion, Canada talks progressing well: Piyush Goyal
» Sensex, Nifty end higher in volatile trade; metal and pharma stocks lead gains
» Govt extends RELIEF scheme for risk coverage of export shipments due to Gulf war
» Tesla India posts Rs 247 crore revenue in first fiscal of vehicle sales
» Indian equities extend losses this week as Brent crude oil rises to 6-month high
SME Times News Bureau | 26 Dec, 2021
Rising Covid-19 cases as well as derivatives expiry and key macro-economic data points will impact the Indian equity market's trajectory during the upcoming week, opined experts.


Besides, flow direction of foreign funds along with crude oil prices will also influence investors' sentiments.

"On daily charts, Nifty has formed a 'Bearish' engulfing pattern. A move below Friday's low, i.e., 16,909 could result in faster fall in the coming week which also may see low volumes as most institutional players are on year end leave," said Deepak Jasani, Head of Retail Research, HDFC Securities.

"However an upward breach of 17,118-17,155 could result in better momentum on the upside."

Notably, market participants are expected to track macro-data such as the Index of ECI (eight core industries) and fiscal deficit numbers which will be released during the trade week starting December 27.

"Indian market post the recent pullback, recouped some of the losses amidst volatility and ended almost flat," said Siddhartha Khemka, Head - Retail Research, Broking & Distribution, Motilal Oswal Financial Services.

"While the relief rally might continue for some more time, volatility also cannot be ruled out on account of potential risk from the Omicron variant and fragile global cues."

Furthermore, derivatives expiry on December 30, Thursday will be the other major theme for the week starting Monday.

"We have a lack of global cues amid Christmas and New Year holidays and FIIs' flows are also on the tepid side where December month F&O expiry and domestic cues will dominate the next week," said Santosh Meena, Head of Research, Swastika Investmart.

"On the domestic front, rising Covid cases and various restrictions by the state governments are a key concern for the market."

Further, Meena points out that FIIs' volumes have come down significantly, however, they are still on the sell-side.

Last week, FIIs sold equities worth Rs 6,600 crore, while DIIs bought worth Rs 6,900 crore in the cash market.

According to Vinod Nair, Head of Research at Geojit Financial Services: "The Indian market has been undergoing a phase of consolidation for the past two months, which we believe is reaching its last phase in terms of price correction.

"Going forward, the market will continue to remain highly sensitive to developments surrounding the Omicron variant while closely monitoring macroeconomic data like the US jobless claims to be released next week."
 
Print the Page
Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹96.5
₹94.8
UK Pound
₹132.25
₹128.15
Euro
₹113.6
₹109.8
Japanese Yen ₹61.3 ₹59.45
As on 03 Sep, 2026
  Daily Poll
What’s your biggest challenge with the 45-day payment rule?
 Corporates canceling our orders
 Clients demanding longer credit anyway
 Strained business relationships
 Filing complaints kills future work
 No issues, cash flow has improved
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter